Bay Street News, February, 2020

— XPOVIO Net Product Sales of $17.7 Million for Fourth Quarter and $30.5 Million for Full Year 2019 —— XPOVIO Prescription Demand Increased […]

—Strong 2019 marked by clinical data that validates platform——Lead inflammation candidate EDP1815 showed positive clinical data across two separate cohorts——EDP1815 […]

Highlights include:Record annual sales of $3.2 billion for 2019, up 7% from 20182019 operating margin of 10.7%, up 20 bps […]

RP1: Four of the first five cutaneous squamous cell carcinoma (CSCC) patients treated in combination with Opdivo® reported to be […]

– Fourth Quarter TIBSOVO® Net Revenue of $19.6M and $59.9M for Full Year 2019; Full Year 2020 U.S. TIBSOVO® Net […]

MISSISSAUGA, Ontario, Feb. 13, 2020 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical […]

TORONTO, Feb. 13, 2020 (GLOBE NEWSWIRE) — Camrova Resources Inc. (“Camrova” or the “Corporation“) (TSX-V: CAV; OTC: BAJFF; SSE :CAVCL.CAV […]

VANCOUVER, British Columbia, Feb. 13, 2020 (GLOBE NEWSWIRE) — Legend Power® Systems Inc. (TSX.V: LPS) (“Legend Power” or the “Company”), […]

TORONTO, Feb. 13, 2020 (GLOBE NEWSWIRE) — Today, RBC iShares has announced that it is creating more choice for investors […]

TORONTO, 13 févr. 2020 (GLOBE NEWSWIRE) — Aujourd’hui, RBC iShares a annoncé la création d’un plus grand nombre de choix […]